We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$31.9B
AUM Growth
+$1.95B
Cap. Flow
+$433M
Cap. Flow %
1.36%
Top 10 Hldgs %
19.72%
Holding
2,075
New
328
Increased
694
Reduced
841
Closed
117

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$152M
2
VTR icon
Ventas
VTR
+$139M
3
WMB icon
Williams Companies
WMB
+$122M
4
DOC icon
Healthpeak Properties
DOC
+$100M
5
CVX icon
Chevron
CVX
+$78.1M

Sector Composition

Rank Sector Weight
1 Healthcare 15.6%
2 Consumer Staples 12.46%
3 Energy 12.05%
4 Financials 8.62%
5 Utilities 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSI
101
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$61.8M 0.19%
5,119,200
-463,800
-8% -$4.4M
SFM icon
102
Sprouts Farmers Market
SFM
$7.53B
$61.2M 0.19%
1,870,000
NUVA
103
DELISTED
NuVasive, Inc.
NUVA
$61.2M 0.19%
1,719,442
-7,978
-0.5% -$273K
VLO icon
104
Valero Energy
VLO
$90B
$59.5M 0.19%
1,186,748
-786,099
-40% -$43.3M
WLL
105
DELISTED
Whiting Petroleum Corporation
WLL
$59.4M 0.19%
2,467
+49
+2% +$1.09M
E icon
106
ENI
E
$78B
$59.4M 0.19%
1,081,266
+267,768
+33% +$13.9M
PINC
107
DELISTED
Premier
PINC
$58.4M 0.18%
2,013,066
+14
+0% +$420
STWD icon
108
Starwood Property Trust
STWD
$6.16B
$58.4M 0.18%
2,455,072
-61,785
-2% -$1.47M
PGNX
109
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$58.2M 0.18%
13,508,290
-41,500
-0.3% -$158K
APTV icon
110
Aptiv
APTV
$12.3B
$58M 0.18%
844,324
+560,648
+198% +$38M
CCI icon
111
Crown Castle
CCI
$33.2B
$57.9M 0.18%
779,948
+196,912
+34% +$14.8M
ITMN
112
DELISTED
INTERMUNE INC
ITMN
$57M 0.18%
1,292,031
-39,174
-3% -$1.44M
AR icon
113
Antero Resources
AR
$10.9B
$57M 0.18%
868,400
+377,681
+77% +$24M
MSCC
114
DELISTED
Microsemi Corp
MSCC
$56.6M 0.18%
2,115,600
-235,973
-10% -$5.88M
HPQ icon
115
HP
HPQ
$26.1B
$54.9M 0.17%
3,592,063
+606,739
+20% +$9.12M
DVAX
116
DELISTED
Dynavax Technologies
DVAX
$54.6M 0.17%
3,411,500
-59,000
-2% -$890K
XPRO icon
117
Expro Ltd
XPRO
$1.71B
$54.3M 0.17%
368,033
LUMN icon
118
Lumen
LUMN
$6.26B
$54.1M 0.17%
1,495,414
+255,536
+21% +$9.17M
AVGO icon
119
Broadcom
AVGO
$1.78T
$52.1M 0.16%
7,227,680
+76,680
+1% +$515K
SNDK
120
DELISTED
SANDISK CORP
SNDK
$50.6M 0.16%
484,097
-61,199
-11% -$5.56M
ZGNX
121
DELISTED
Zogenix, Inc.
ZGNX
$50.4M 0.16%
3,133,088
-13,375
-0.4% -$242K
LMT icon
122
Lockheed Martin
LMT
$133B
$49.7M 0.16%
309,150
-5,765
-2% -$937K
RDS.A
123
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$49.2M 0.15%
596,989
+222,627
+59% +$17.4M
NVDA icon
124
NVIDIA
NVDA
$4.64T
$48.9M 0.15%
105,511,240
-1,713,680
-2% -$800K
MLCO icon
125
Melco Resorts & Entertainment
MLCO
$2.2B
$48.7M 0.15%
1,362,800
-417,895
-23% -$14.4M

Similar funds

Federated Hermes's Q2 2014 Portfolio in Review

As of Q2 2014, Federated Hermes held 2,075 positions worth $31.9B, up 6.5% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Federated Hermes's Q2 2014 filing shows 328 new, 694 increased, 841 reduced and 117 closed positions. Its largest new stake was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M. The largest sale was AstraZeneca, an estimated $276M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q2 2014 buy was ATHLON ENERGY INC COM: 939,555 shares worth $44.8M.
  • Federated Hermes added most to Illumina in Q2 2014, an estimated $152M increase.
  • Federated Hermes's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $276M.
  • Federated Hermes fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q2 2014, selling an estimated $39.7M.
  • Federated Hermes's ten largest holdings make up 20% of its $31.9B portfolio in Q2 2014.
  • Federated Hermes opened 328 new positions and closed 117 in Q2 2014.
  • Federated Hermes's portfolio value rose 6.5% quarter-over-quarter to $31.9B.

Based on Federated Hermes's 13F filing for Q2 2014, filed 7 Aug 2014.